Citation: | GUO Jian, XIA Yichun, ZHAO Lei, QIAN Fenghua, ZHOU Xionggen, QIAN Yiming. Clinical efficacy of bi-level positive airway pressure combined withmedication aerosol inhalation on treatment of chronic obstructive pulmonary disease patients with type Ⅱ respiratory failure[J]. Journal of Clinical Medicine in Practice, 2013, (23): 23-25,34. DOI: 10.7619/jcmp.201323007 |
Halpin D M, Tashkin D P. Defining disease modification in chronic obstructive pulmonary disease [J]. COPD, 2009(3):211.
|
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊断指南(2007年修订版) [J]. {H}中华结核和呼吸杂志, 2007(1):7.
|
Rabe K F, Hurd S, Anzueto A. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease:GOLD executive summary [J]. {H}American Journal of Respiratory and Critical Care Medicine, 2007(6):532.
|
Rothberg M B, Pekow P S, LAHTI M. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) [J]. Journal of hospital Medicine, 2010(5):261.
|
乔中会, 李俊萍. 慢性阻塞性肺疾病急性加重期患者死亡原因探讨 [J]. {H}临床肺科杂志, 2012(7):1309.doi: 10.3969/j.issn.1009-6663.2012.07.074.
|
陈军红. 双水平正压通气在AECOPD并发肺性脑病患者中的疗效 [J]. {H}中国老年学杂志, 2011, (13):2437.
|
蒋智钦, 谢君英. 爱全乐与万托林雾化吸入联合BiPAP呼吸机无创治疗COPD合并Ⅱ型呼吸衰竭的疗效观察 [J]. 中华中西医学杂志, 2009(6):19.
|
刘书院, 赖善福. 氨溴索联合干扰素雾化吸入治疗慢性支气管炎急性发作43例分析 [J]. {H}中国医药导报, 2010, (28):155.doi: 10.3969/j.issn.1673-7210.2010.28.089.
|
包明红, 梅晓东. 慢性阻塞性肺疾病急性加重期联合吸入药物治疗的临床研究 [J]. {H}临床肺科杂志, 2011(7):1018.doi: 10.3969/j.issn.1009-6663.2011.07.018.
|
Celli B R, Cote C G, Marin J M. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J]. {H}New England Journal of Medicine, 2004, (10):1005.
|